Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism

[1]  D. Rubens,et al.  Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial. , 2017, Thrombosis research.

[2]  A. Khorana,et al.  Cancer and Venous Thromboembolic Disease: A Review. , 2017, The oncologist.

[3]  V. Miller,et al.  Methodology for isolation, identification and characterization of microvesicles in peripheral blood. , 2012, Journal of immunological methods.

[4]  Christian Weber,et al.  Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange , 2010, Circulation research.

[5]  N. Ditsch,et al.  CEA-, Her2/neu-, BCRP- and Hsp27-positive microparticles in breast cancer patients. , 2010, Anticancer research.

[6]  D. Neuberg,et al.  Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy , 2009, Clinical Cancer Research.

[7]  A. Khorana,et al.  Assessing risk of venous thromboembolism in the patient with cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  P. Fontana,et al.  Cell-derived microparticles in haemostasis and vascular medicine , 2009, Thrombosis and Haemostasis.

[9]  Lianbo Yu,et al.  Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.

[10]  I. Bauerfeind,et al.  Platelet-derived microparticles and coagulation activation in breast cancer patients , 2008, Thrombosis and Haemostasis.

[11]  J. Colon,et al.  Tissue factor‐bearing microparticles derived from tumor cells: impact on coagulation activation , 2008, Journal of thrombosis and haemostasis : JTH.

[12]  T. Lecompte,et al.  Low-molecular weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2008 .

[13]  I. Bauerfeind,et al.  Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. , 2008, Anticancer research.

[14]  J. Freyssinet,et al.  Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.

[15]  L. Helman,et al.  Thromboembolic events in children and young adults with pediatric sarcoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  C. Ludlam,et al.  Plasma microparticles and vascular disorders , 2007, British journal of haematology.

[17]  S. Eichinger,et al.  Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer , 2006, Thrombosis and Haemostasis.

[18]  R. D. de Winter,et al.  P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. , 2006, Clinical chemistry.

[19]  F. Rosendaal,et al.  Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study , 2006, Journal of thrombosis and haemostasis : JTH.

[20]  H. Chew,et al.  Incidence of venous thromboembolism and its effect on survival among patients with common cancers. , 2006, Archives of internal medicine.

[21]  M. Bauer,et al.  Platelet-derived microvesicles induce differential gene expression in monocytic cells: A DNA microarray study , 2006, Platelets.

[22]  José A López,et al.  Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. , 2005, Blood.

[23]  Anna Janowska-Wieczorek,et al.  Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer , 2005, International journal of cancer.

[24]  M. Prins,et al.  Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. , 2003, The New England journal of medicine.

[25]  M. Levine,et al.  Venous Thromboembolism and Cancer: Risks and Outcomes , 2003, Circulation.

[26]  K. Mann,et al.  Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism , 2003, Circulation.

[27]  A. Matzdorff,et al.  Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. , 2002, Thrombosis research.

[28]  B. Østerud.  The role of platelets in decrypting monocyte tissue factor. , 2001, Disease-a-month : DM.

[29]  G. Lip,et al.  Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[30]  L. Horstman,et al.  Platelet microparticles: a wide-angle perspective. , 1999, Critical reviews in oncology/hematology.

[31]  G. FitzGerald,et al.  Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. , 1997, The Journal of clinical investigation.

[32]  T. Lihoreau,et al.  Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanoma. , 2014, The Journal of investigative dermatology.

[33]  Y. Ikeda,et al.  Function and role of microparticles in various clinical settings. , 2008, Thrombosis research.

[34]  M. Ratajczak,et al.  Evidence that platelet-derived microvesicles may transfer platelet-specific immunoreactive antigens to the surface of endothelial cells and CD 34 + hematopoietic stem / progenitor cells-implication for the pathogenesis of immune thrombocytopenias , 2007 .

[35]  H. K. Kim,et al.  Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. , 2003, European journal of cancer.

[36]  B. Osterud.  The role of platelets in decrypting monocyte tissue factor. , 2001, Seminars in hematology.

[37]  Robert C. Wolpert,et al.  A Review of the , 1985 .